- ViVE 2025: Abridge scores $250M at $2. 75B valuation
ViVE 2025: Abridge scores $250M, adds new AI tool to streamline 'billable notes' By Heather Landi Feb 17, 2025 12:00pm Abridge Artificial Intelligence ViVE 2025
- Abridge Series D Announcement and More
As a pioneer in generative AI for healthcare, Abridge is setting the industry standard for the responsible deployment of AI across health systems Abridge was recently awarded Best in KLAS for Ambient AI segment in addition to other accolades, including TIME Best Inventions of 2024, 2024 Forbes AI 50 List, and Fortune’s 2024 AI 50 Innovators
- Healthcare startup Abridge raises $250 million to enhance AI . . .
Feb 17 (Reuters) - Abridge, a startup that uses artificial intelligence to build medical documents, said on Monday it raised $250 million in a funding round co-led by Elad Gil and IVP Investors
- Abridge revenue, valuation funding | Sacra
Abridge is valued at approximately $2 75B based on its February 2025 Series D round of $250 million co-led by Elad Gil and IVP, representing a significant jump from its $850 million valuation following the $150 million Series C round just one year earlier in February 2024
- Abridge lands $250M: 4 things to know - Beckers Hospital . . .
Abridge lands $250M: 4 things to know Healthcare AI company Abridge has landed $250 million in its latest investment round Advertisement By: Giles Bruce Tuesday, February 18th, 2025
- Abridge Raises $250M in Series D Funding - finsmes. com
Abridge, San Francisco, CA-based provider of a generative AI platform for clinical conversations, raised $250M in Series D funding The round was co-led by Elad Gil and IVP, with participation
- Abridge Raises at $5B Valuation; David AI, Gail, Siro . . .
AI healthcare startups Abridge and Ambience Healthcare are both in advanced stages of raising new funding rounds Abridge is reportedly in talks to raise hundreds of millions of dollars at a $5 billion valuation, nearly double its $2 75 billion valuation from a $250 million Series D round in February and following a $150 million Series C in 2024
|